Hartung HP - Search Results

1

[Promoting remyelination as a future therapeutic principle in multiple sclerosis?].

Pöhlau D, Aktas O, Epplen C, Hartung HP, Hoffmann V, Przuntek H. Pöhlau D, et al. Among authors: hartung hp. Nervenarzt. 1998 Oct;69(10):841-50. doi: 10.1007/s001150050352. Nervenarzt. 1998. PMID: 9834472 Review. German.

2

[Physical trauma and multiple sclerosis].

Weilbach FX, Hartung HP. Weilbach FX, et al. Among authors: hartung hp. Nervenarzt. 1997 Dec;68(12):940-4. doi: 10.1007/s001150050220. Nervenarzt. 1997. PMID: 9465335 Review. German.

3

[Intravenous immunoglobulins in multiple sclerosis. Studies and mechanisms of action--an update].

Stangel M, Hartung HP. Stangel M, et al. Among authors: hartung hp. Nervenarzt. 2002 Feb;73(2):119-24. doi: 10.1007/s00115-001-1235-6. Nervenarzt. 2002. PMID: 11975087 Review. German.

4

[Plasma exchange as a therapeutic option in neurological disorders].

Lehmann HC, Hartung HP, Hetzel GR, Kieseier BC. Lehmann HC, et al. Among authors: hartung hp. Nervenarzt. 2007 Feb;78(2):166, 168-70, 172-6. doi: 10.1007/s00115-006-2229-1. Nervenarzt. 2007. PMID: 17268791 Review. German.

5

[Intravenous immunoglobulins in therapy of intermittent multiple sclerosis. An update].

Fazekas F, Strasser-Fuchs S, Hartung HP. Fazekas F, et al. Among authors: hartung hp. Nervenarzt. 1998 Apr;69(4):361-5. doi: 10.1007/s001150050284. Nervenarzt. 1998. PMID: 9606690 Clinical Trial. German.

6

[Immune augmenting therapy as treatment of multiple sclerosis. Warning regarding a potentially toxic alternative treatment method].

Pette M, Hartung HP, Toyka KV. Pette M, et al. Among authors: hartung hp. Nervenarzt. 1994 Dec;65(12):878-90. Nervenarzt. 1994. PMID: 7854511 German. No abstract available.

7

[Course of illness and prognosis of multiple sclerosis. 2: Predictive value of clinical and paraclinical factors].

Flachenecker P, Hartung HP. Flachenecker P, et al. Among authors: hartung hp. Nervenarzt. 1996 Jun;67(6):444-51. Nervenarzt. 1996. PMID: 8767198 Review. German.

8

[Formation of neutralizing antibodies in therapy of multiple sclerosis with interferon beta-1b. Practical procedure in suspected therapeutic failure].

Walther EU, Dang T, Hartung HP, Hohlfeld R. Walther EU, et al. Among authors: hartung hp. Nervenarzt. 1997 Dec;68(12):935-9. doi: 10.1007/s001150050219. Nervenarzt. 1997. PMID: 9465334 Review. German.

9

[15+/-deoxyspergualin, hope for patients with multiple sclerosis?].

Kappos L, Theobald K, Hartung HP. Kappos L, et al. Among authors: hartung hp. Nervenarzt. 1992 Dec;63(12):768-71; discussion 772. Nervenarzt. 1992. PMID: 1494394 Review. German. No abstract available.

10

[Matrix metalloproteinases. Potential targets for new treatments in inflammatory demyelinating diseases of the nervous system].

Kieseier BC, Seifert T, Hartung HP. Kieseier BC, et al. Among authors: hartung hp. Nervenarzt. 1999 Jun;70(6):509-16. doi: 10.1007/s001150050473. Nervenarzt. 1999. PMID: 10412695 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,138 results

Search Page

Filters